CompletedNot Applicable

Efficacy Evaluation Of Great Occipital Nerve Electrical Stimulation On Rebound Headache

France30 participantsStarted 2010-11

Plain-language summary

SENGO-CAM study is a sham-controlled simple blind trial which aim is to study the efficacy of great occipital nerve stimulation (GONS) associated with medication withdrawal in the treatment of medication overuse headache occurring in migraine patients.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * age \> 18 years old * migraine patient with medication overuse headache by non specific analgesics according to the ICHD-II diagnostic criteria * failure of outpatient withdrawal * Signature of informed consent. * Affiliation to French national health and pensions organization Exclusion Criteria: * pregnancy (positive pregnancy test at pre-study) and breast-feeding * patients with medication overuse headache by specific antimigraine treatment (triptans or/and ergot derivatives) according to the ICHD-II diagnostic criteria * previous surgical treatment targeting great occipital nerves

What they're measuring

Primary endpoint will be the comparison of the rate of headache-free patients, fourteen days after medication withdrawal, in both groups (GONS versus sham)

Timeframe: 14 days

Trial details

NCT IDNCT01184222

SponsorCentre Hospitalier Universitaire de Nice

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2011-01

View on ClinicalTrials.gov More HEADACHE trials